Advertisement
Canada markets open in 4 hours 16 minutes

  • S&P/TSX

    21,885.38
    +11.66 (+0.05%)
     

  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     

  • DOW

    38,085.80
    -375.12 (-0.98%)
     

  • CAD/USD

    0.7327
    +0.0004 (+0.05%)
     

  • CRUDE OIL

    83.72
    +0.15 (+0.18%)
     

  • Bitcoin CAD

    87,969.19
    +507.96 (+0.58%)
     

  • CMC Crypto 200

    1,388.97
    -7.57 (-0.54%)
     

  • GOLD FUTURES

    2,360.70
    +18.20 (+0.78%)
     

  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     

  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     

  • NASDAQ futures

    17,728.75
    +161.25 (+0.92%)
     

  • VOLATILITY

    15.59
    +0.22 (+1.43%)
     

  • FTSE

    8,106.22
    +27.36 (+0.34%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • CAD/EUR

    0.6819
    -0.0002 (-0.03%)
     

Stocks in play: Neovasc Inc.

Baystreet.ca
Updated

Announced that the U.S. Food and Drug Administration has granted Breakthrough Device designation to the Neovasc Reducer™, a medical device for the treatment of refractory angina, which is not currently approved for commercial sale in the U.S. Neovasc Inc. shares T.NVCN are trading up $0.89 at $4.06.